Alissar Monzer

608 total citations
20 papers, 460 citations indexed

About

Alissar Monzer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alissar Monzer has authored 20 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alissar Monzer's work include Cancer Cells and Metastasis (4 papers), Prostate Cancer Treatment and Research (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Alissar Monzer is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Prostate Cancer Treatment and Research (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Alissar Monzer collaborates with scholars based in Lebanon, United States and Canada. Alissar Monzer's co-authors include Wassim Abou‐Kheir, Hisham F. Bahmad, Farah Ballout, Georges Daoud, Ola Hadadeh, Deborah Mukherji, Katia Cheaito, Reda Chalhoub, Albert El Hajj and Assaad A. Eid and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Alissar Monzer

20 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alissar Monzer Lebanon 10 211 203 88 70 64 20 460
Farah Ballout United States 13 229 1.1× 181 0.9× 84 1.0× 70 1.0× 48 0.8× 30 530
Raghupathy Vengoji United States 15 422 2.0× 242 1.2× 197 2.2× 85 1.2× 33 0.5× 21 679
Vineshkumar Thidil Puliyappadamba United States 14 391 1.9× 161 0.8× 136 1.5× 87 1.2× 20 0.3× 15 643
Ji-Hak Jeong South Korea 15 369 1.7× 151 0.7× 182 2.1× 60 0.9× 31 0.5× 24 684
Ángelo Torres Chile 14 315 1.5× 99 0.5× 153 1.7× 41 0.6× 54 0.8× 21 609
Chengsen Chai China 9 385 1.8× 160 0.8× 138 1.6× 68 1.0× 35 0.5× 10 561
Liuqi Yang China 7 284 1.3× 138 0.7× 132 1.5× 20 0.3× 30 0.5× 11 451
Sasikumar J. Soumya India 5 246 1.2× 54 0.3× 83 0.9× 32 0.5× 23 0.4× 8 440
Xueting Shao China 8 194 0.9× 100 0.5× 82 0.9× 29 0.4× 41 0.6× 14 443

Countries citing papers authored by Alissar Monzer

Since Specialization
Citations

This map shows the geographic impact of Alissar Monzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissar Monzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissar Monzer more than expected).

Fields of papers citing papers by Alissar Monzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissar Monzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissar Monzer. The network helps show where Alissar Monzer may publish in the future.

Co-authorship network of co-authors of Alissar Monzer

This figure shows the co-authorship network connecting the top 25 collaborators of Alissar Monzer. A scholar is included among the top collaborators of Alissar Monzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissar Monzer. Alissar Monzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monzer, Alissar, et al.. (2025). 225 Ac/ 89 Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer. Journal of Nuclear Medicine. 66(4). 592–598. 3 indexed citations
2.
3.
Monzer, Alissar, Farah Ballout, Samar Al Bitar, et al.. (2024). ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids. Pharmacological Reports. 77(1). 229–246. 3 indexed citations
4.
Monzer, Alissar, Neda Shafiabadi Hassani, Brian D. Gray, et al.. (2024). Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1305–1320. 2 indexed citations
5.
Monzer, Alissar, et al.. (2024). Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate. Clinical Cancer Research. 31(4). 685–696. 6 indexed citations
6.
Monzer, Alissar, Farah Ballout, Samar Al Bitar, et al.. (2022). Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional in vitro models. World Journal of Gastroenterology. 28(33). 4787–4811. 4 indexed citations
7.
Bitar, Samar Al, Farah Ballout, Alissar Monzer, et al.. (2022). Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models. Cancers. 14(6). 1363–1363. 22 indexed citations
8.
Cheaito, Katia, Hisham F. Bahmad, Ola Hadadeh, et al.. (2021). Establishment and characterization of prostate organoids from treatment‑naïve patients with prostate cancer. Oncology Letters. 23(1). 6–6. 20 indexed citations
9.
Bahmad, Hisham F., Darine Daher, Ola Hadadeh, et al.. (2021). The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update. International Journal of Molecular Sciences. 22(14). 7667–7667. 55 indexed citations
10.
Bahmad, Hisham F., Reda Chalhoub, Hayat Harati, et al.. (2020). Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β. Pharmacological Reports. 73(1). 211–226. 24 indexed citations
11.
12.
Bahmad, Hisham F., Wenjing Peng, Rui Zhu, et al.. (2020). Protein Expression Analysis of an In Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets. Journal of Personalized Medicine. 10(3). 83–83. 6 indexed citations
13.
Ballout, Farah, Alissar Monzer, Maamoun Fatfat, et al.. (2020). Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells. Oncotarget. 11(31). 2959–2972. 34 indexed citations
14.
15.
Bahmad, Hisham F., Alissar Monzer, Ola Hadadeh, et al.. (2019). The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem‐like cells. Molecular Carcinogenesis. 58(7). 1208–1220. 19 indexed citations
16.
Bahmad, Hisham F., Katia Cheaito, Reda Chalhoub, et al.. (2018). Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells. Frontiers in Oncology. 8. 347–347. 156 indexed citations
17.
Bahmad, Hisham F., Tarek H. Mouhieddine, Reda Chalhoub, et al.. (2018). PO-283 The Akt/mTOR pathway in cancer stem/progenitor cells is a therapeutic target for glioblastoma and neuroblastoma. ESMO Open. 3. A131–A131. 2 indexed citations
18.
Daoud, Georges, Alissar Monzer, Hisham F. Bahmad, et al.. (2016). Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines. Oncotarget. 7(20). 28961–28975. 12 indexed citations
19.
Mouhieddine, Tarek H., Amaly Nokkari, Muhieddine M. Itani, et al.. (2015). Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells. Frontiers in Neuroscience. 9. 442–442. 49 indexed citations
20.
El‐Merahbi, Rabih, Yen‐Nien Liu, Assaad A. Eid, et al.. (2014). Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells. PLoS ONE. 9(11). e112453–e112453. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farah Ballout Breakdown of academic impact, for papers by Raghupathy Vengoji Breakdown of academic impact, for papers by Vineshkumar Thidil Puliyappadamba Breakdown of academic impact, for papers by Ji-Hak Jeong Breakdown of academic impact, for papers by Ángelo Torres Breakdown of academic impact, for papers by Chengsen Chai Breakdown of academic impact, for papers by Liuqi Yang Breakdown of academic impact, for papers by Sasikumar J. Soumya Breakdown of academic impact, for papers by Xueting Shao
Rankless by CCL
2026